PRAMIPEXOLE/TU - Search Results

Year	Number of Results
2017	5
2018	20
2019	20
2020	17
2021	15
2022	19
2023	2

1

Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis.

Tundo A, de Filippis R, De Crescenzo F. Tundo A, et al. Acta Psychiatr Scand. 2019 Aug;140(2):116-125. doi: 10.1111/acps.13055. Epub 2019 Jun 9. Acta Psychiatr Scand. 2019. PMID: 31111467

2

Pramipexole regulates depression-like behavior via dopamine D3 receptor in a mouse model of Parkinson's disease.

Wei SZ, Yao XY, Wang CT, Dong AQ, Li D, Zhang YT, Ren C, Zhang JB, Mao CJ, Wang F, Liu CF. Wei SZ, et al. Brain Res Bull. 2021 Dec;177:363-372. doi: 10.1016/j.brainresbull.2021.10.015. Epub 2021 Oct 24. Brain Res Bull. 2021. PMID: 34699917

3

Pramipexole to Improve Cognition in Bipolar Disorder: A Randomized Controlled Trial.

Van Meter AR, Perez-Rodriguez MM, Braga RJ, Shanahan M, Hanna L, Malhotra AK, Burdick KE. Van Meter AR, et al. J Clin Psychopharmacol. 2021 Jul-Aug 01;41(4):421-427. doi: 10.1097/JCP.0000000000001407. J Clin Psychopharmacol. 2021. PMID: 33956703 Free PMC article. Clinical Trial.

4

P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's Disease.

Hauser RA, Giladi N, Poewe W, Brotchie J, Friedman H, Oren S, Litman P. Hauser RA, et al. Adv Ther. 2022 May;39(5):1881-1894. doi: 10.1007/s12325-022-02097-2. Epub 2022 Mar 10. Adv Ther. 2022. PMID: 35267155 Free PMC article. Review.

5

Pramipexole nanocrystals for transdermal permeation: Characterization and its enhancement micro-mechanism.

Li Y, Wang D, Lu S, Zeng L, Wang Y, Song W, Liu J. Li Y, et al. Eur J Pharm Sci. 2018 Nov 1;124:80-88. doi: 10.1016/j.ejps.2018.08.003. Epub 2018 Aug 2. Eur J Pharm Sci. 2018. PMID: 30076954

6

Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke.

Andrabi SS, Ali M, Tabassum H, Parveen S, Parvez S. Andrabi SS, et al. Dis Model Mech. 2019 Aug 29;12(8):dmm033860. doi: 10.1242/dmm.033860. Dis Model Mech. 2019. PMID: 31235613 Free PMC article.

7

Iron for the treatment of restless legs syndrome.

Trotti LM, Becker LA. Trotti LM, et al. Cochrane Database Syst Rev. 2019 Jan 4;1(1):CD007834. doi: 10.1002/14651858.CD007834.pub3. Cochrane Database Syst Rev. 2019. PMID: 30609006 Free PMC article.

8

Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial.

Levi L, Zamora D, Nastas I, Gonen I, Radu P, Matei V, Ciobanu AM, Nacu A, Boronin L, Karakrah L, Davidson M, Davis JM, Weiser M. Levi L, et al. J Clin Psychiatry. 2022 Aug 1;83(5):21m14233. doi: 10.4088/JCP.21m14233. J Clin Psychiatry. 2022. PMID: 35921506 Clinical Trial.

9

Delusional infestation caused by pramipexole.

Romero Sandoval K, Festa Neto C, Nico MMS. Romero Sandoval K, et al. Clin Exp Dermatol. 2018 Mar;43(2):192-193. doi: 10.1111/ced.13292. Epub 2017 Oct 10. Clin Exp Dermatol. 2018. PMID: 28994135 No abstract available.

10

Efficacy of pramipexole on quality of life in patients with Parkinson's disease: a systematic review and meta-analysis.

Li T, Zou S, Zhang Z, Liu M, Liang Z. Li T, et al. BMC Neurol. 2022 Aug 25;22(1):320. doi: 10.1186/s12883-022-02830-y. BMC Neurol. 2022. PMID: 36008796 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results